Corrigendum to: Modern-Day Therapeutics and Ongoing Clinical Trials against Type 2 Diabetes Mellitus: A Narrative Review
Related Experiment Video
Updated: Jul 16, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Rohit Kumar Tiwari1, Afza Ahmad2, Muskan Chadha3
1Department of Clinical Research, Sharda School of Allied Health Sciences, Sharda University, Gautam Buddh Nagar, Uttar Pradesh, 201310, India.
Abstract:
In the originally published article titled "Modern-Day Therapeutics and Ongoing Clinical Trials against Type 2 Diabetes Mellitus: A Narrative Review", published in "Current Diabetes Reviews", Vol: 21, 2025 [1], certain phrases and expressions were unclear, which may have affected readability. These have now been revised to improve clarity and ensure that the intended meaning is accurately conveyed. The corrections do not affect the results, interpretations, or conclusions of the article. We apologize for any inconvenience caused and appreciate the opportunity to rectify this matter. The original article can be found online at https://www.eurekaselect.com/article/140414 Original: 4.1.3. GLP-1 Receptor Agonist According to the latest press release, DD01 is therapeutic against hepatic steatosis and lowers body weight in T2DM patients diagnosed with or without fatty liver ailment. Corrected: 4.1.3. GLP-1 Receptor Agonist According to the latest press release, DD01 is therapeutic against hepatic steatosis and lowers body weight in T2DM patients diagnosed with or without fatty liver disorder.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction